Details of the Drug

General Information of Drug (ID: DMDO13Y)

Drug Name
6-Styryl-naphthalene-2-carboxamidine
Synonyms CHEMBL185345; 6-Styryl-naphthalene-2-carboxamidine; ZINC28365935
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 272.3
Logarithm of the Partition Coefficient (xlogp) 4.4
Rotatable Bond Count (rotbonds) 3
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 1
Chemical Identifiers
Formula
C19H16N2
IUPAC Name
6-[(E)-2-phenylethenyl]naphthalene-2-carboximidamide
Canonical SMILES
C1=CC=C(C=C1)/C=C/C2=CC3=C(C=C2)C=C(C=C3)C(=N)N
InChI
InChI=1S/C19H16N2/c20-19(21)18-11-10-16-12-15(8-9-17(16)13-18)7-6-14-4-2-1-3-5-14/h1-13H,(H3,20,21)/b7-6+
InChIKey
YRAFBVUQILDIDH-VOTSOKGWSA-N
Cross-matching ID
PubChem CID
21707121
TTD ID
D00POF

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cationic trypsinogen (PRSS1) TT2WR1T TRY1_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties. Bioorg Med Chem Lett. 2005 Jan 3;15(1):93-8.